Zhang Yaping (1973-), table tennis player, several times world and Olympic winner
associate
-
yzhang@renyuelegal.com
-
13701857754
Personal Profile
Ms. Zhang specializes in handling complex regulatory compliance matters, internal investigations, and cross-border investment risk assessments. She has extensive experience in representing leading global companies in government regulatory investigations, building compliance systems, and handling cross-border commercial litigation.
Mr. Zhang has represented medical device manufacturers, life sciences leaders, private equity firms, and investment advisors in a wide range of legal issues involving SEC regulation, sanctions compliance, anti-money laundering, export controls, intellectual property protection, and FCPA violations. With a strong background in U.S.-China law, Mr. Zhang is able to provide a full range of legal counseling to clients, with a particular focus on compliance risk management in the Asia-Pacific region.
representative case
- Provided U.S. regulatory compliance counseling to a number of international companies, with particular expertise in CFIUS, foreign investment programs, sanctions and export controls, assisting clients with safe and effective international business expansion.
- Represented a pharmaceutical company in an internal anti-corruption investigation, successfully identifying and addressing key compliance risk points to help the organization avoid potential regulatory penalties and reputational damage.
- Provides legal advice on data compliance, privacy protection and intellectual property strategies for multinational companies in the technology industry, assisting clients to effectively manage legal risks in the course of internationalization.
- Represented a leading medical device manufacturer in SEC regulatory matters involving the Middle East, China, and Southeast Asia, as well as providing legal advice in connection with an SEC investigation related to misconduct by the manufacturer's distributor in a Southeast Asian country.
- Regularly represents leading private equity firms and investment companies in internal investigations of potential misconduct at their portfolio companies and advises on potential litigation strategies.
- Represented the firm and its special committees in internal investigations of potential sanctions violations, FCPA violations, and trade secret violations, and successfully assisted clients in responding to regulatory examinations in multiple jurisdictions.
- Regularly represent a leading Registered Investment Advisor ("RIA") in the development and implementation of its compliance program, including the development and regular updating of compliance policies and procedures covering key risk areas such as anti-corruption, anti-money laundering, sanctions, export controls and broader national security considerations.
- Drafted a compliance program for a leading Exempt Reporting Advisor ("ERA") to address its key risk areas such as anti-corruption, sanctions, conflicts of interest, personal trading, public trading, insider trading, political donations, investment opportunity allocation, cybersecurity, business continuity, valuation, and more.
- Regularly represents a U.S.-based registered investment advisor and a leading Hong Kong-based investment firm in connection with its acquisitions in Asia, covering a wide range of risk areas (anti-corruption, sanctions, anti-money laundering, etc.) and multiple industries (healthcare, infrastructure, manufacturing, consumer goods, financial services, etc.).
- Represented a newly established Chinese RMB fund in setting up its compliance program and portfolio company due diligence process to ensure compliance with relevant domestic and international regulatory requirements.
- Represented major technology companies in litigation related to their patents, trademarks, trade secrets and creative misappropriation, and advised on pre-litigation strategies.
- Regularly represents leading companies in the life sciences sector in their internal corporate investigations in the Asia Pacific region regarding potential FCPA violations, bidding improprieties, antitrust violations, distributor improprieties, questionable sales practices, executive improprieties, supply chain improprieties, and other issues.
- *Some of the above sensitive information has been withheld due to attorney-client confidentiality obligations. The above representative examples include practice prior to joining this platform. *
natural endowments
- U.S. Attorney's License for the State of Illinois (2016)
- Qualification for legal practice in China (2021)
- Harvard Law School, J.D., 2016
- Murray Edwards College, University of Cambridge, Master of Philosophy in the History of Political Thought, 2011
- Peking University, B.S. in Microelectronics and completed the required courses for the major of Politics, Economics and Philosophy, 2010
Chinese
English (language)
Korean (oral communication)
Publications
XX Magazine
Published on XX date
XX Articles
Frontier Articles
Ren Yue Insight | Tariffs Series: U.S. Tariff Planning, Applying for Tariff Exemptions, Preventing Trade Defaults</trp-post-container
The U.S. government has recently begun to impose additional taxes on countries around the world